National Immunisation Schedule
The national immunization schedule spans from birth through adulthood, with specific vaccines administered at defined ages to prevent vaccine-preventable diseases and reduce morbidity and mortality across the lifespan. 1
Infancy (Birth to 11 Months)
Birth
2 Months
- Second dose HepB 2
- DTaP (Diphtheria, Tetanus, Pertussis) - first dose 1, 2
- Haemophilus influenzae type b (Hib) - first dose 1, 2
- Pneumococcal conjugate vaccine (PCV) - first dose 1, 2
- Inactivated Poliovirus (IPV) - first dose 1, 2
- Rotavirus - first dose (between 6-12 weeks of age) 1, 2
4 Months
- DTaP - second dose 1, 2
- Hib - second dose 1, 2
- PCV - second dose 1, 2
- IPV - second dose 1, 2
- Rotavirus - second dose 1, 2
6 Months
- HepB - third dose (complete series by 6-18 months) 1, 2
- DTaP - third dose 1, 2
- Hib - third dose (depending on vaccine brand) 1, 2
- PCV - third dose 1, 2
- IPV - third dose 1, 2
- Rotavirus - third dose if applicable (complete by 32 weeks of age) 1, 2
- Influenza vaccine: Begin annual vaccination (two doses separated by 28 days for first-time recipients) 1, 2
Early Childhood (12 Months to 6 Years)
12-15 Months
- Hib - fourth dose 1, 3
- PCV - fourth dose 1, 3
- MMR (Measles, Mumps, Rubella) - first dose 1, 3
- Varicella - first dose 1, 3
- Hepatitis A (HepA) - first dose of two-dose series 1, 3
15-18 Months
18-23 Months
4-6 Years
Adolescence (11-18 Years)
11-12 Years
- Tdap (Tetanus, diphtheria, acellular pertussis) - single dose 1, 3
- HPV (Human Papillomavirus) - two-dose series (0,6-12 months) for both males and females 1, 3
- Meningococcal ACWY (MenACWY) - first dose 1, 3
16 Years
- MenACWY - booster dose 1, 3
- Meningococcal B (MenB) - may be administered based on individual clinical decision (ages 16-23, preferably 16-18) 1
Annual Throughout Childhood and Adolescence
Adulthood (19 Years and Older)
Routine Adult Vaccinations
- Td or Tdap booster - every 10 years 1
- Influenza vaccine - annually 1
- Pneumococcal vaccines: 1
- Ages 19-64 with chronic conditions: PPSV23
- Age 65+: PCV13 followed by PPSV23 at least 1 year later
- Zoster (Shingles) vaccine (RZV) - two-dose series for adults age 50+ (2-6 months apart) 1
- HPV vaccine - catch-up through age 26 for those not previously vaccinated 1
Special Populations
- Pregnant women: Tdap during each pregnancy (preferably weeks 27-36) 1
- Healthcare personnel: MMR (two doses if born 1957 or later), varicella (two doses if no immunity) 1
- Immunocompromised adults: Modified schedules with additional doses of pneumococcal and meningococcal vaccines 1
Important Clinical Considerations
Simultaneous administration of all indicated vaccines at the same visit is strongly recommended to maximize immunization rates and ensure timely protection. 1
Key Principles
- Catch-up schedules exist for delayed immunizations - vaccine series never needs to be restarted regardless of time elapsed between doses 1
- Minimum intervals: Doses given ≥4 days before minimum interval are considered valid; doses given ≥5 days early must be repeated 1
- Combination vaccines can be used whenever components are indicated and not contraindicated 1
- Adverse events should be reported to VAERS (Vaccine Adverse Event Reporting System) 1
Common Pitfalls to Avoid
- Do not delay the birth dose of hepatitis B vaccine without physician order and documented negative maternal HBsAg 1
- Do not start rotavirus series after 12 weeks of age or give any dose after 32 weeks of age 1
- Do not count measles vaccine doses given before 12 months of age as part of the routine series 1
- Ensure proper vaccine storage and handling to maintain efficacy 1